If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Higher CV Event Rate Linked to Low Hb in HD Patients

May 11, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients receiving either epoetin or peginesatide who achieve low hemoglobin (Hb) levels have an increased rate of cardiovascular (CV) events, according to new data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.
 

Post-Angiography AKI May Deter Heart Drug Use

April 28, 2012

ST. JOHN'S, NEWFOUNDLAND—Older patients who have coronary angiography and then experience acute kidney injury (AKI) are significantly less likely to receive cardiovascular medications than their counterparts who do not develop AKI, a new study shows.
 

Dialysis May Help Some Patients with Treatment-Resistant CHF

April 11, 2012

Dialysis may improve outcomes in patients suffering from treatment-resistant congestive heart failure (CHF) accompanied by severe renal insufficiency, new findings suggest.
 

Heart Failure Linked to Orthostatic Hypotension

April 10, 2012

Orthostatic hypotension predicts incident heart failure among middle-aged adults, especially those aged 45-55 years old, researchers reported online ahead of print in Hypertension.
 

Endothelial Dysfunction in CKD Patients Linked to Calcitonin

April 05, 2012

Serum calcitonin is independently related with endothelial dysfunction in patients with chronic kidney disease (CKD), data suggest.
 

Kidney Donation Does Not Increase CV Risk

April 01, 2012

Kidney donors are at no greater risk for cardiovascular (CV) events or death than non-donors.
 

Arteriovenous Fistulas May Increase Heart Failure Risk

March 21, 2012

Pre-emptive placement of an arteriovenous fistula (AVF) in pre-dialysis patients with advanced chronic kidney disease (CKD) may increase their risk of congestive heart failure (CHF), a study found.
 

Nut Consumers Have Lower Health Risks

March 07, 2012

Nut consumption is associated with a decreased prevalence of certain risk factors for cardiovascular disease, type 2 diabetes, and metabolic syndrome, according to a recent study.
 

Renal Dysfunction After Radical Nephrectomy Raises Cardiovascular Risks

February 25, 2012

PARIS—Renal dysfunction following radical nephrectomy (RN) for renal cancer is associated with an increased risk of cardiovascular (CV) events and non-cancer-related mortality, Japanese researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Change in Fitness or Fatness Impacts Cardio Risk Factors

February 06, 2012

Positive change in fitness or fatness impacts cholesterol, hypertension, metabolic syndrome
 

Severe Vitamin D Deficiency Raises Death Risk in Hemodialysis Patients

February 02, 2012

Hemodialysis (HD) patients with severe vitamin D deficiency are more than twice as likely to die from any cause compared with those who have sufficient levels of the vitamin, according to a German study.
 

Newer Antihypertensive Agents May Be No Better than Diuretics

January 20, 2012

Calcium channel blockers (CCBs) and ACE inhibitors may be no better than diuretics at preventing cardiovascular deaths in patients with hypertension, according to a follow-up study of patients in a seminal antihypertensive trial. In addition, CCBs and ACE inhibitors may increase cardiovascular risks.
 

Myocardial Infarctions Frequently Unrecognized in Kidney Disease Patients

January 04, 2012

Myocardial infarction (MI) often goes unrecognized in patients with chronic kidney disease (CKD), and it is associated with a significantly increased risk of death, according to researchers.
 

EPO Resistance May Predict Cardiovascular Events

December 05, 2011

Early identification of erythropoietin (EPO) resistance may help clinicians predict cardiovascular risk in hemodialysis (HD) patients, according to researchers.
 

No Benefit To Adding Niacin to Statin Rx

December 01, 2011

Adding niacin to statin therapy offers no incremental clinical benefit to patients with atherosclerotic cardiovascular disease and LDL cholesterol levels below 70 mg/dL, according to study findings published in the New England Journal of Medicine (online ahead of print).
 

Telephone Intervention Can Help Obese Patients Lose Weight

November 16, 2011

ORLANDO—A weight loss program delivered by telephone can be just as effective in obese patients with at least one cardiovascular risk factor as a weight loss program delivered with in-person support, researchers reported at the American Heart Association Scientific Sessions 2011.
 

Kidney Transplants Fail to Stop Coronary Artery Calcification

November 02, 2011

Renal transplantation does not stop or reverse coronary artery calcification (CAC), according to researchers.
 

CVD Varies by Race in CKD Population

November 01, 2011

Researchers who studied a cohort of individuals with mild-to-moderate chronic kidney disease have identified racial differences in the prevalence of self-reported cardiovascular disease (CVD) and indicators of subclinical CVD.
 

Drug-Eluting Stents Safe for Most Older CKD Patients

October 20, 2011

Drug-eluting stents are safe to use in older patients undergoing percutaneous coronary interventions regardless of renal function, researchers concluded.
 

Two RRT Modalities Offer Similar Survival

October 01, 2011

PRAGUE—Two forms of renal replacement therapy (RRT) for end-stage renal disease are associated with similar rates of mortality overall and from cardiovascular (CV) causes, according to a new study.
 

Erectile Dysfunction Helps Identify Silent CAD in Diabetic Men

September 15, 2011

Erectile dysfunction (ED) can improve the effectiveness of screening diabetic men for asymptomatic coronary artery disease (CAD), according to researchers.
 

Fruits, Vegetables Boost BP Control

September 13, 2011

PARIS—A diet rich in fruits and vegetables can lower blood pressure in patients with coronary heart disease, according to data presented at the European Society of Cardiology annual meeting.
 

Ambulatory BP Predicts Renal and CV Events

August 15, 2011

In a study of 436 patients with chronic kidney disease not on dialysis (mean age 65.1 years), ambulatory blood pressure (BP) measurements showed risk of both renal and cardiovascular (CV) events to be highest when daytime systolic BP was 135 mm Hg or higher, when diastolic BP was in the highest quintile, and when nighttime systolic BP was 124 mm Hg or higher.
 

Survival Better with HD than PD in CHF Patients

July 21, 2011

PRAGUE—For patients with congestive heart failure (CHF) who initiate maintenance dialysis, those starting on peritoneal dialysis (PD) have a significantly greater death risk than those starting on hemodialysis (HD), according to a French study.
 

PP Declines Predict Worse HD Patient Survival

July 20, 2011

PRAGUE—Decreases in pulse pressure (PP), and to a lesser extent increases, predict worse survival in the first year for patients new to hemodialysis (HD), new findings suggest.
 

LDL Lowering Fails to Slow Renal Disease Progression

July 19, 2011

PRAGUE—Lowering LDL cholesterol (LDL) can prevent or even reverse atherosclerosis, but it does not do the same for the progression of chronic kidney disease (CKD).
 

HDL from CDK Patients Loses Vasoprotective Effects

July 18, 2011

PRAGUE—HDL cholesterol (HDL) in patients with chronic kidney disease (CKD) loses its protective effect on vascular endothelium, new findings suggest. Rather than supporting the beneficial functions of the endothelium, it appears to become pro-inflammatory and inhibit them.
 

NP-Based Program Helps Control CKD Cardiac Risk Factors

July 18, 2011

PRAGUE—A multifactorial intervention using a polydrug and lifestyle treatment strategy with nurse practitioner (NP) support can improve management of some cardiovascular (CV) risk factors and reduced the number of physician visits by patients with chronic kidney disease (CKD).
 

BP Meds at Bedtime Reduce CVD Risk

June 28, 2011

PRAGUE—Taking antihypertensive medications at bedtime significantly reduces cardiovascular disease (CVD) risk compared with ingesting the drugs upon awakening, according to researchers.
 

CV Risk Lower with Metformin

June 27, 2011

SAN DIEGO—Older patients with type 2 diabetes have a significantly higher likelihood of experiencing a cardiovascular (CV) event within two years if they start treatment with a sulfonylurea drug than with metformin, researchers reported at the 71st Scientific Sessions of the American Diabetes Association.
 

LVEF Predicts Mortality in Very Elderly Patients

May 26, 2011

NEW YORK—Reduced left ventricular ejection fraction (LVEF) is associated with an increased likelihood of cardiovascular (CV) and all-cause mortality in very elderly patients, data show. This association is independent of traditional CV risk factors, according to investigators.
 

Dual Regimen Benefits Obese Patients

May 12, 2011

NEW ORLEANS—The combination of sustained-release naltrexone and bupropion leads to sustained clinically meaningful weight loss and improves markers of cardiovascular risk in obese patients, according to results released at the 60th Annual Scientific Session of the American College of Cardiology.
 

Tx Patients Fail to Meet SBP Targets

May 03, 2011

PHILADELPHIA—Most renal transplant recipients (RTRs) fail to achieve recommended systolic blood pressure (SBP) levels despite being prescribed antihypertensive medications. Consequently, they may be at increased risk for cardiovascular disease (CVD), a study found.
 

Obese Donors Not At Higher Renal Risk

May 02, 2011

PHILADELPHIA—Obese kidney donors are not at elevated risk for renal dysfunction long term, but they may experience an increase in risk factors for cardiovascular disease (CVD), according to researchers.
 

ECG Findings May Identify Transplant Candidates at Higher Death Risk

May 01, 2011

PHILADELPHIA—Abnormalities revealed by electrocardiography (ECG) may predict which patients undergoing evaluation for a renal transplant are at higher risk of death, a study found. These abnormalities include prolonged PR or QTc intervals.
 

Early Steroid Withdrawal Cuts CV Event Rates in Transplant Recipients

May 01, 2011

PHILADELPHIA—Kidney transplant patients who undergo early corticosteroid withdrawal (ECSWD) have a significantly better survival free of cardiovascular (CV) events, according to investigators. The decrease in CV event does not become apparent until three or four years after transplantation.
 

CV Risk Factors Undertreated in High-Risk CKD Patients

April 30, 2011

LAS VEGAS—Modifiable cardiovascular (CV) risk factors remain undertreated in a very high-risk population of patients with chronic kidney disease (CKD), new findings presented at the National Kidney Foundation's Spring Clinical Meetings suggest.
 

Bisphosphonates Lower Death Risk Among Women with CKD

April 30, 2011

LAS VEGAS—Bisphosphonate treatment in women with non-dialysis dependent chronic kidney disease (NDD-CKD) is associated with a decreased risk of death, but not of cardiovascular events, according to data presented at the National Kidney Foundation's Spring Clinical Meetings.
 

Vitamin D Replacement May Lower CV Event Risk

April 29, 2011

LAS VEGAS—Treatment of 25-hydroxyvitamin D (25(OH)D) deficiency with ergocalciferol in patients with moderate chronic kidney disease (CKD) is associated with a significant reduction in the risk of cardiovascular (CV) events, new data presented at the National Kidney Foundation's Spring Clinical Meetings suggest.
 

Study: Women Are At Higher Risk of RCIN

April 29, 2011

LAS VEGAS—Women with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m2 or higher are at higher risk than men for experiencing radiocontrast-induced nephropathy (RCIN) following coronary angiography, investigators reported at the National Kidney Foundation's Spring Clinical Meetings.
 

Morning Blood Pressure Surge May Not Increase Death Risk

April 22, 2011

Morning blood pressure (BP) surge is widely believed to increase cardiovascular disease risk, but a new study suggests that an increase in morning BP over nocturnal levels may represent a healthier form of circadian variation and may not have an adverse predictive nature but rather a favorable one when it comes to all-cause mortality.
 

Computer Tool Cuts Medication Errors in ACS Patients on Dialysis

April 18, 2011

NEW ORLEANS—New data demonstrate that a computer-assisted decision support (CADS) tool can significantly reduce the number of medication errors and adverse events, particular major bleeding, that occur in patients with acute coronary syndromes (ACS) who require dialysis.
 

CAC Score Predicts Cardiac Events in CKD Patients

April 12, 2011

Assessment of coronary artery calcification (CAC) and progression may be useful for earlier management of risk factors for cardiac events in patients with chronic kidney disease (CKD), according to an Italian study.
 

High Plasma Renin Activity May Worsen Outcomes

April 11, 2011

VANCOUVER, B.C.—High plasma renin activity (PRA) is associated with adverse renal outcomes in patients with coronary artery disease (CAD), according to study findings presented at the World Congress of Nephrology.
 

Statin May Lower Risk of CV Events, Death Among HD Patients

April 11, 2011

VANCOUVER, B.C.—Statin treatment may decrease the risk of cardiovascular (CV) events and all-cause mortality in hemodialysis (HD) patients, according to researchers.
 

CKD Increases Risk of Death in Patients with Peripheral Vascular Disease

April 04, 2011

NEW ORLEANS—Chronic kidney disease (CKD), defined as a glomerular filtration rate of 60 mL/min/1.73 m2 or below, is an independent predictor of death in patients with peripheral vascular disease (PVD), researchers reported at the 60th Annual Scientific Session of the American College of Cardiology.
 

CKD Develops in Many Living Kidney Donors

March 19, 2011

VIENNA—One year after undergoing living donor nephrectomy (LDN), more than half of donors will have chronic kidney disease (CKD), according to a British study. Their decline in renal function, however, appears to remain stable for at least five years and patients rarely suffer adverse cardiovascular events and cardiac mortality.
 

Kidney Gene Found To Boost Likelihood of Heart Failure

March 14, 2011

In an unexpected finding, a defect in a kidney gene—not a heart gene—appears to predispose a person to heart failure.
 

Kidney Stones Raise Atherosclerosis Risk

March 14, 2011

An analysis of data from the CARDIA study reinforces the idea that nephrolithiasis and atherosclerosis have common systemic risk factors and/or pathophysiology.
 

Preventive Therapy for ST-Elevation MI Underused

February 24, 2011

CHICAGO—Evidence-based cardiovascular preventive medications are underused in patients presenting with ST-elevation myocardial infarction (STEMI), investigators reported at the American Heart Association Scientific Sessions.
 

Women Diabetics on Dialysis Fare Worse than Men

February 24, 2011

Diabetic women on dialysis had a strikingly higher mortality risk than their diabetic male counterparts in a recent study published in Nephrology Dialysis Transplantation (2011;26:270-276).
 

CAB Surgery May Be Superior to Stents Long Term

February 24, 2011

DENVER—Drug-eluting stents (DES) provide the best short-term survival for dialysis patients who require coronary revascularization, but coronary artery bypass (CAB) surgery may offer better long-term survival, researchers reported at the 2010 Renal Week conference.
 

New Study Reveals Kidney Gene Responsible for Heart Failure

February 16, 2011

Researchers have found that it is not a heart gene responsible for heart failure, but a kidney gene. The new findings have significant clinical implications.
 

Mammograms May Be Helpful in Detecting Heart Disease

February 14, 2011

Mammograms may be helpful in detecting heart disease in women with end-stage renal disease. John Schieszer has that story in today's Medical Minute.
 

Lipid Lowering Reduces Cardiovascular Risk in CKD Patients

January 24, 2011

Cholesterol-lowering treatment with a combination of ezetimibe and simvastatin significantly decreases the likelihood of major atherosclerotic events in patients with chronic kidney disease (CKD), according to the findings of the five-year Study of Heart and Renal Protection (SHARP) trial.
 

Six Hemodialysis Sessions May Be Better than Three

January 24, 2011

Doubling the conventional schedule of three hemodialysis (HD) sessions per week improved left ventricular mass and physical health among participants of the Frequent Hemodialysis Network (FHN) Daily Trial.
 

Elderly MI Survivors Often Fail to Take Prescribed Meds

January 18, 2011

Long-term medication adherence after myocardial infarction (MI) in the elderly is low, especially in patients with kidney dysfunction, according to a study published online in the Clinical Journal of the American Society of Nephrology.
 

Post-MI Sufferers with Renal Impairment Fail to Take Heart Meds

January 18, 2011

Medication adherence is low among patients with reduced renal function who have suffered a myocardial infarction (MI), according to a study published in the Clinical Journal of the American Society of Nephrology (2011; online ahead of print).
 

Diabetes Incidence Varies by Ethnicity, Gender

January 11, 2011

The incidence of diagnosed diabetes varies significantly among ethnic groups, according to a Canadian study. Overall, South Asians have the highest incidence and Chinese subjects have the lowest.
 

Lowering Cholesterol Reduces CV Event Risk in CKD Patients

December 08, 2010

DENVER—Cholesterol-lowering treatment with a combination of ezetimibe and simvastatin significantly decreases the likelihood of major atherosclerotic events in patients with chronic kidney disease (CKD), according to the findings of the five-year Study of Heart and Renal Protection (SHARP) trial.
 

Elevated iPTH Hikes Cardiovascular Event Risk in CKD Patients

November 19, 2010

Elevated levels of serum intact parathyroid hormone (iPTH) in patients with stage III and IV CKD may be associated with an increase in the risk of cardiovascular (CV) events, according to a new study presented at REnal Week 2010 in Denver.
 

Cardiovascular Mortality Linked to FGF-23

November 19, 2010

Elevated levels of fibroblast growth factor 23 (FGF-23) are associated with an increased risk for cardiovascular (CV) death among elderly men independent of renal function and other parameters of mineral metabolism, according to Swedish researchers who presented their findings at Renal Week 2010 in Denver.
 

Cardiovascular Mortality Rate Declining in Dialysis Patients

November 18, 2010

Although the cardiovascular mortality rate (CVMR) among dialysis patients is declining, the risk of cardiovascular mortality is increasing over time compared with the general population, according to Australian researchers who presented their findings at Renal Week 2010 in Denver.
 

New Finding May Shed Light on Phosphorus-CVD Link

November 18, 2010

Serum phosphorus is independently associated with angiopoietin 2 in renal transplant patients, and this could help explain why high serum phosphorus levels increase the risk of cardiovascular disease (CVD), according to investigators who presented a study at Renal Week 2010 in Denver.
 

Restless Legs Syndrome Raises Cardiovascular Risks

November 09, 2010

Restless legs syndrome (RLS) increases the risk of new cardiovascular events and cardiovascular mortality among patients with end-stage renal disease (ESRD), according to Italian researchers.
 

Stone Formers Found to Be at Higher Risk for MI

August 19, 2010

Individuals who form kidney stones are at increased risk for myocardial infarction (MI) independent of CKD and other risk factors, according to researchers.
 

Cardiovascular Events Halt Study of Testosterone Gel

August 19, 2010

A study of testosterone supplementation in older men was terminated after daily application of a testosterone gel was associated with a significantly increased risk of cardiovascular (CV) adverse events.
 

Coronary Heart Disease Linked to Endogenous Testosterone

August 18, 2010

A greater than twofold increased risk observed in men with the highest versus the lowest levels.
 

High-Dose Statin Therapy Has Expanded Benefits

July 28, 2010

Patients with both heart disease and CKD experience decreased risk of cardiovascular events.
 

ED Raises Risk of Calcified Coronary Arteries

July 27, 2010

SAN FRANCISCO—New research implicates erectile dysfunction (ED) as an independent risk factor for high-risk coronary artery calcification.
 

Cardiac Patients with Kidney Disease Fare Worse

July 27, 2010

Kidney disease is present in nearly one third of patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and it is a strong independent predictor of subsequent mortality, new findings show.
 

Gout Drug Has Cardiac Benefit

June 29, 2010

MUNICH, GERMANY—Allopurinol, a drug long used to treat gout, can cause regression of left ventricular hypertrophy (LVH) and improvement of endothelial dysfunction in CKD patients, a study found.
 

Statin May Benefit Diabetic HD Patients with High Cholesterol

June 26, 2010

MUNICH, GERMANY—Atorvastatin may benefit hemodialysis (HD) patients with type 2 diabetes and high LDL cholesterol levels, a researcher reported at the the European Renal Association-European Dialysis and Transplant Association 2010 Congress.
 

Elevated FGF-23 Bad for CKD Patients

June 14, 2010

It predicts an increased risk of cardiovascular events and death in those not on dialysis.
 

Dialysis Patients May Benefit from Omega-3 Fatty Acids

June 10, 2010

Supplementation could provide a low-cost way to protect against cardiovascular events.
 

Renal Outcomes Linked to LVMI

June 10, 2010

NEW YORK—In men at high risk of cardiovascular events, left ventricular mass index (LVMI) may help better predict renal outcomes, including the need for hemodialysis (HD), researchers reported here at the American Society of Hypertension 25th Annual Scientific Meeting and Exposition.
 

Microalbuminuria Found to Increase Risk of Chronic Kidney Disease

May 12, 2010

Increased levels of protein in urine may indicate a higher risk of developing kidney and cardiovascular problems among individuals with hypertension.
 

Study Identifies High Prevalence of Ischemic Stroke at the Start of Dialysis

April 23, 2010

Approximately one in 15 patients starting dialysis have had an ischemic stroke, according to researchers.
 

ESA Resistance Linked to Variant Hemoglobin in African Americans

April 15, 2010

Variant hemoglobin phenotypes, including sickle cell trait and hemoglobin C trait, may be associated with resistance to treatment with erythropoietin-stimulating agents (ESAs) among African Americans with end-stage renal disease (ESRD).
 

Erectile Dysfunction Signals Higher Death and Cardiovascular Risk

April 09, 2010

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD).
 

Hypokalemia Endangers CKD Patients with Heart Failure

April 01, 2010

Low potassium levels increase mortality risk by 56%, data show.
 

New Indication Approved for Rosuvastatin

March 30, 2010

Crestor (rosuvastatin calcium) has received FDA approval to market the drug as a treatment for reducing the risk of stroke, myocardial infarction (MI), and arterial revascularization.
 

Reduced Salt Intake Could Yield Big Benefits

March 30, 2010

Modest reductions in dietary salt intake can help reduce the risk of cardiovascular events and significantly lower medical costs, a study found.
 

Study Challenges Benefits of Intensive BP Control in Patients with Diabetes

March 19, 2010

Intensive BP control does not reduce the rate of a composite outcome of fatal and nonfatal cardiovascular events in patients with type 2 diabetes, according to researchers.
 

Fatigue Increases Cardiovascular Risk in ESRD Patients

February 25, 2010

Cardiovascular events are twice as likely to occur in highly fatigued patients, recent study shows.
 

Albuminuria and Heart Disease Linked Only in White Diabetics

January 22, 2010

Albuminuria is strongly associated with the severity of calcified atherosclerotic plaque (CP) in white but not black individuals with type 2 diabetes, according to a new study.
 

Statin May Prevent Cardiovascular Disease in Kidney Disease Patients

January 15, 2010

Lovastatin may prevent development of cardiovascular disease (CVD) in CKD patients, according to study findings published in the American Journal of Kidney Diseases (2009; published online ahead of print).
 

Binder Prevents CAC Progression

January 12, 2010

SAN DIEGO—Lanthanum carbonate stops progression of coronary artery calcification (CAC) in hemodialysis (HD) patients, preliminary data from a small pilot study suggest.
 

Impaired Renal Function Raises Risk of Advanced Coronary Atherosclerosis

January 08, 2010

Coronary atherosclerosis severity is significantly associated with decreased renal function, according to researchers.
 

Endocrine Therapy for Prostate Cancer May Hike Cardiovascular Disease Risk

December 17, 2009

Study reveals an increased risk of MI and other heart problems.
 

A New Look at High Hb Goals

December 10, 2009

Heart failure and diabetes could make reported risks clinically undetectable.
 

Dialysis Patients Often Given Wrong Antithrombotics for PCI

December 08, 2009

Researchers who studied a group of dialysis patients undergoing percutaneous coronary intervention (PCI) found that one fifth of them received antithrombotic medications that were contraindicated or not recommended.
 

Telmisartan Okayed for Cardiovascular Risk Reduction

November 19, 2009

Boehringer Ingelheim Pharmaceuticals has received approval for a new indication for its angiotensin II receptor blocker Micardis (telmisartan).
 

Revascularization No Better than Medical Therapy for Renal Artery Stenosis

November 12, 2009

Revascularization offers little or no "worthwhile clinical benefit" over medical treatment for patients with renal artery stenosis, regardless of the extent of their renal disease, researchers concluded.
 

High-Dose Multivitamin Does Not Reduce CVD Outcomes in Transplant Patients

November 01, 2009

Treatment of stable renal transplant recipients with a regimen of high-dose folic acid and vitamins B6 and B12 lowers total homocysteine levels better than a low-dose multivitamin containing no folic acid.
 

Study: Cardiovascular Risk Reduction Lacking in Kidney Transplant Patients

October 30, 2009

Despite the fact that cardiovascular diseases are the leading cause of death in kidney transplant patients, overall utilization of cardioprotective drugs—such as antihypertensive agents and statins—is low in this high-risk population, Hungarian researchers reported at ASN's Renal Week 2009.
 

Higher Phosphorus Levels, Atherosclerosis Linked

October 29, 2009

Higher phosphorus levels are associated with peripheral atherosclerosis and arterial stiffness, independent of traditional risk factors for cardiovascular disease (CVD), according to a study.
 

UACR, eGFR Predict Diabetics' Outcomes

September 17, 2009

These two values are independently associated with the likelihood of cardiovascular and renal events.
 

Coronary Artery Calcification Linked to Vitamin D Deficiency

August 10, 2009

Study reveals a 23% increased risk with each 10 ng/mL decrease in 25-hydroxyvitamin D concentration.
 

Heart Drug May Benefit HD Patients

July 23, 2009

Oral nicorandil, an anti-angina medication, may decrease the risk of cardiac death and improve survival of hemodialysis (HD) patients after coronary revascularization, according to researchers.
 
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Dialysis End-stage Renal Disease Hemodialysis Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urinary Tract Infection Urology UTI

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions